Treadwell Therapeutics Inc. announced that it has received more than $91,000,000 in a round of funding co- led by new investor, Sino Biopharmaceutical Limited and 3W Fund Management Limited on November 18, 2021. The transaction also includes participation from new investors, Prosperous Alliance Investments Limited, Alpha Win Capital Limited, China Fortune Ocean Equity Investment Fund Co., Ltd., Adrian Cheng, returning investor, TIO Bioventures and other undisclosed institutional and individual investors.